5:01 PM
 | 
Jan 09, 2013
 |  BC Extra  |  Financial News

Spinomix raises $3 million in A round

Molecular diagnostic technologies company Spinomix S.A. (Lausanne, Switzerland) raised $3 million in a series A round led by new investor Debiopharm Group (Lausanne, Switzerland). Spinomix's founders and an undisclosed private...

Read the full 131 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >